Bonjesta

Active Ingredient(s): Doxylamine Succinate + Pyridoxine Hydrochloride
FDA Approved: * November 7, 2016
Pharm Company: * DUCHESNAY
Category: Nausea & Vomiting

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Bonjesta Overview

Doxylamine is a first-generation antihistamine used as a short-term sedative and hypnotic (sleep aid) or in combination formulations to provide night-time allergy and cold relief. It provides a calmative effect in preparations containing the analgesics paracetamol (acetaminophen) and codeine. It is prescribed in combination with vitamin B6 (pyridoxine) to prevent morning sickness in pregnant women. Its fetal safety rating is "A" (no evidence of risk).[4] It was first described...

Read more Bonjesta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Doxylamine

Recent Bonjesta Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Doxylamine Succinate + Pyridoxine Hydrochloride
  • Tablet, Extended Release: 20mg + 20mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Bonjesta: (1 result)

Sorted by National Drug Code
  • 55494-120 Bonjesta Oral Tablet, Extended Release by Duchesnay USA, Inc.

Drugs with one or more similar ingredients: (3 results)